Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04288024
Other study ID # 201907085RIND
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 25, 2020
Est. completion date June 22, 2020

Study information

Verified date February 2020
Source National Taiwan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

(1) postural and suprapostural performance of a dual task would be differently affected by the strategy of task prioritization and (2) the cortical activation is different according to attentional focus strategies.


Description:

These hypothesis would be tested by gait performance, suprapostural accuracy and relative power spectrum of EEG.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date June 22, 2020
Est. primary completion date June 22, 2020
Accepts healthy volunteers No
Gender All
Age group 50 Years to 85 Years
Eligibility Inclusion Criteria: - 1. modified H-Y stage II-III Parkinson's disease 2. No other diseases 3. Non-demented PD 4. Non-tremor PD Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms

  • Parkinson Disease
  • Postural and Suprapostural Performance During Dual Tasking in Patients With Parkinson's Disease

Intervention

Behavioral:
Weight-shifting training
Postural task: Participants are standing with their weak side on the force plate. During the task, they wight-shift from side to side ranging from 10 to 90 percent of their body weight. Suprapostural task: Participants hold a tray with their arms beside the body, 90 degrees of elbow flexion. They rotate the tray left and right for 45 degrees respectively. During their task, participants should weight-shift and rotate the tray at the same time.

Locations

Country Name City State
Taiwan National Taiwan University Taipei

Sponsors (1)

Lead Sponsor Collaborator
National Taiwan University Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary EEG relative power in the delta band postural and suprapostural performance of a dual task 60 minutes
Primary EEG relative power in the theta band postural and suprapostural performance of a dual task 60 minutes
Primary EEG relative power in the alpha band postural and suprapostural performance of a dual task 60 minutes
Primary EEG relative power in the beta band postural and suprapostural performance of a dual task 60 minutes
Primary EEG relative power in the gamma band postural and suprapostural performance of a dual task 60 minutes
Primary COP trajectory recorded from the force plate performance of the postural task 60 minutes
Primary Angles from inclinometer performance of the suprapostural task 60 minutes
Secondary Gait velocity from GAITRite gait performance 5 minutes
Secondary Cadence from GAITRite gait performance 5 minutes
Secondary Mean step length from GAITRite gait performance 5 minutes
Secondary Step-to-step variability from GAITRite gait performance 5 minutes